Back
ARS Pharmaceuticals Stock Price Chart
Sponsored
SPRY
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARS Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.65 | Buy |
20-day SMA: | 12.71 | Buy |
50-day SMA: | 11.83 | Buy |
200-day SMA: | 8.83 | Buy |
8-day EMA: | 12.95 | Buy |
20-day EMA: | 12.6 | Buy |
50-day EMA: | 11.79 | Buy |
200-day EMA: | 9.39 | Buy |
ARS Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 63.23 | Buy |
Chaikin Money Flow: | 629993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.04 - 13.82) | Buy |
Bollinger Bands (100): | (8.53 - 12.15) | Buy |
ARS Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ARS Pharmaceuticals Stock
Is ARS Pharmaceuticals Stock a Buy?
- ARS Pharmaceuticals share price is 14.05 while SPRY 8-day simple moving average is 12.65, which is a Buy signal.
- The stock price of SPRY is 14.05 while ARS Pharmaceuticals 20-day SMA is 12.71, which makes it a Buy.
- ARS Pharmaceuticals 50-day simple moving average is 11.83 while SPRY share price is 14.05, making it a Buy technically.
- SPRY stock price is 14.05 and ARS Pharmaceuticals 200-day simple moving average is 8.83, creating a Buy signal.
SPRY Technical Analysis vs Fundamental Analysis
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy or a Sell?
-
ARS Pharmaceuticals stock is rated a Sell
The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
ARS Pharmaceuticals Stock Info
Market Cap:
1.36B
Price in USD:
14.05
Share Volume:
1.13M
ARS Pharmaceuticals 52-Week Range
52-Week High:
16.50
52-Week Low:
2.55
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
ARS Pharmaceuticals Share Price Forecast
-
What is the ARS Pharmaceuticals stock price today?
The ARS Pharmaceuticals stock price is 14.05 USD today. -
Will SPRY stock go up or go down?
ARS Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is ARS Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ARS Pharmaceuticals is overvalued.
Is ARS Pharmaceuticals Stock a Buy?
- ARS Pharmaceuticals share price is 14.05 while SPRY 8-day exponential moving average is 12.95, which is a Buy signal.
- The stock price of SPRY is 14.05 while ARS Pharmaceuticals 20-day EMA is 12.60, which makes it a Buy.
- ARS Pharmaceuticals 50-day exponential moving average is 11.79 while SPRY share price is 14.05, making it a Buy technically.
- SPRY stock price is 14.05 and ARS Pharmaceuticals 200-day simple moving average is 9.39, creating a Buy signal.
Fundamental Analysis of ARS Pharmaceuticals
Is ARS Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.26 per share.
Technical Analysis of ARS Pharmaceuticals
Should I short ARS Pharmaceuticals stock?
- SPRY Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting ARS Pharmaceuticals is a Buy
- ARS Pharmaceuticals Relative Strength Index (RSI) is 63.23, which suggest ARS Pharmaceuticals is overbought
- The Bollinger Bands (25) for ARS Pharmaceuticals is (12.04 - 13.82), which suggest ARS Pharmaceuticals is a Buy
- The Bollinger Bands (100) for ARS Pharmaceuticals is (8.53 - 12.15), which suggest ARS Pharmaceuticals is a Buy
* ARS Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.